Harbour begins phase III study in China of HBM-9036 for moderate to severe dry eye March 16, 2021 No Comments
FDA clears IND for izokibep as treatment of noninfectious nonanterior uveitis March 11, 2021 No Comments
Preliminary topline data reported from phase IIb ALTISSIMO study of GB-102 March 10, 2021 No Comments
Positive topline data from phase II program of AZR-MD-001 in Meibomian gland dysfunction March 4, 2021 No Comments
VP-001 restores the barrier function of RPE monolayer in patient-derived models of RP11 March 3, 2021 No Comments
First patient dosed in phase II study of OTX-DED for short-term treatment of dry eye disease March 2, 2021 No Comments